Gossamer Bio Inc reports results for the quarter ended in March - Earnings Summary

Gossamer Bio

10/05/2022 23:09

* Gossamer Bio Inc  GOSS.OQ  reported a quarterly adjusted
loss
of 76 cents​​ per share for the quarter ended in March. The mean
expectation of eight analysts for the quarter was for a loss
of 77 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Gossamer Bio Inc's reported EPS for the quarter was a loss
of 76
cents​.
    * The mean earnings estimate of analysts had risen by
about 4.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Gossamer Bio Inc shares had fallen by 26.2% this
quarter and
lost 43.3% so far this year.
    * The company reported a quarterly loss of $57.79 million.
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $15.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 10:08 p.m.  ​All
figures in US dollars unless otherwise stated